Reduction of parathyroid hormone with vitamin D supplementation in blacks: A randomized controlled trial

  • Paulette D. Chandler
  • , Foluso Agboola
  • , Kimmie Ng
  • , Jamil B. Scott
  • , Bettina F. Drake
  • , Gary G. Bennett
  • , Andrew T. Chan
  • , Bruce W. Hollis
  • , Karen M. Emmons
  • , Charles S. Fuchs
  • , Edward L. Giovannucci

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Background: Response of parathyroid hormone (PTH) to vitamin D supplementation is determined by the baseline PTH level and change in vitamin D status. Conflicting reports in Blacks exist on the PTH response to vitamin D to supplementation. Methods: During 3 winters from 2007 to 2010, 328 healthy Blacks (median age, 51 years) living in Boston, MA were randomized into a 4-arm, double-blind trial for 3 months of placebo, 1000, 2000, or 4000 IU of vitamin D3. PTH was measured in 254 participants at baseline and at the end of vitamin D supplementation period. Results: The differences in PTH between baseline and 3 months were 3.93 pg/mL for those receiving placebo, -3.37 pg/mL for those receiving 1000 IU/d, -6.76 pg/mL for those receiving 2000 IU/d, and -8.99 pg/mL for those receiving 4000 IU/d (-2.98 pg/mL for each additional 1000 IU/d of vitamin D3; p < 0.001). Conclusion: We found a significant decrease in PTH with increasing doses of vitamin D supplementation up to intakes of 4000 IU/d in Blacks. Trial registration: Clinical Trials.gov:

Original languageEnglish
Article number26
JournalBMC Nutrition
Volume1
Issue number1
DOIs
StatePublished - Jul 30 2015

Keywords

  • Blacks
  • Parathyroid hormone
  • Supplementation
  • Vitamin D

Fingerprint

Dive into the research topics of 'Reduction of parathyroid hormone with vitamin D supplementation in blacks: A randomized controlled trial'. Together they form a unique fingerprint.

Cite this